Effects of short-term treatment with the bisphosphonates zoledronate and pamidronate on rat bone: A comparative histomorphometric study on the cancellous bone formed before, during, and after treatment

Anatomical Record

Volumn 249, Issue 4, 1997, Pages 458-468

  Pataki, Alexander ^a   Müller, Klaus ^a   Green, Jonathan R ^a   Ma, Yan Fei ^b   Li, Qing Nan ^b   Jee, Webster S S ^b  

^a NOVARTIS PHARMA AG   (Switzerland)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Bisphosphonate; Bone histomorphometry; Pamidronate; Rat; Zoledronate

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCEIN; CALCIUM; DEMECLOCYCLINE; HYDROXYPROLINE; PAMIDRONIC ACID; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE REMODELING; BONE TURNOVER; CANCELLOUS BONE; CONTROLLED STUDY; CORTICAL BONE; DOSE RESPONSE; DRUG EFFECT; GROWTH PLATE; MALE; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TIBIA; TRABECULAR BONE;

NON-PROGRAMMATIC;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; BONE DEVELOPMENT; CALCIUM; DEMECLOCYCLINE; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMUR; FLUORESCEINS; GROWTH PLATE; HYDROXYPROLINE; IMIDAZOLES; INDICATORS AND REAGENTS; INJECTIONS, SUBCUTANEOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; TIBIA;

EID: 0030829844     PISSN: 0003276X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0185(199712)249:4<458::AID-AR5>3.0.CO;2-N     Document Type: Article

References (26)

1. Compston, J.E., N.J. Garrahan, P.I. Croucher, C.D.P. Wright, and K. Yamaguchi 1993 Quantitative analysis of trabecular bone structure. Bone, 14:187-192.
2. de Vernejoul, M.C., A. Pointillart, C. Bergot, J. Bielakoff, C. Morieux, A.M.L. Jeantet, and L. Miravet 1987 Different schedules of administration of (3 amino-1-hydroxypropylidene)-1 1 bisphosphonate induce different changes in pig bone remodeling. Calcif. Tissue Int., 40:160-165.
3. Frost, H.M. 1983 Bone histomorphometry: Analysis of trabecular bone dynamics. In: Bone Histomorphometry: Techniques and Interpretation. RR Recker, ed. CRC Press Inc, Boca Raton, Florida, p. 120.
4. Frost, H.M. 1986a Intermediary Organization of the Skeleton, Vol. 1. CRC Press, Boca Raton, Florida, p. 119.
5. Frost, H.M. 1986b Intermediary Organization of the Skeleton, Vol. 2. CRC Press, Boca Raton, Florida, p. 105.
6. Frost, H.M., and W.S.S. Jee 1992 On the rat model of human osteopenias and osteoporoses. Bone Miner., 18:227-236.
7. Green, J.R., K. Müller, and K.A. Jaeggi 1994 Preclinical pharmacology of CGP 42446, a new, potent, heterocyclic bisphosphonate compound. J. Bone Miner. Res., 2:745-751.
8. Gunness-Hey, M., and J.M. Hock 1984 Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab. Bone Dis. Rel. Res., 5:177-181.
9. Hansson, L.I., K. Minander-Sellman, A. Senstrom, and K.G. Thorngren 1972 Rate of normal longitudinal bone growth in the rat. Calcif. Tissue Res., 10:238-251.
10. Jamall, I.S., V.N. Finelli, and S.S. Que Hee 1981 A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal. Biochem., 12:70-75.
11. Ke, H.Z., W.S.S. Jee, H. Ito, R.B. Setterberg, M. Li, B.Y. Lin, X.G. Liang, and Y.F. Ma 1993 Greater bone formation induction occurred in aged than young cancellous bone sites. Bone, 14:481-485.
12. Kimmel, D.B., and W.S.S. Jee 1980a A quantitative histologic analysis of the growing long bone metaphysis. Calcif. Tissue Int., 32:113-122.
13. Kimmel, D.B., and W.S.S. Jee 1980b Bone cell kinetics during longitudinal bone growth in the rat. Calcif. Tissue Int., 32:123-133.
14. Li, X.J., W.S.S. Jee, H.Z. Ke, S. Mori, and T. Akamine 1991 Age-related changes of cancellous and cortical bone histomorphometry in female Sprague-Dawley rats. Cells Materials, Suppl 1:25-35.
15. 2 alone in the long-term treatment of ovariectomized-induced osteopenic rats. Bone, 17 Suppl. 267S-272S.
16. Miller, S.C., and W.S.S. Jee 1979 The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat. Anat. Rec., 193:439-462.
17. Mühlbauer, R.C., F. Bauss, R. Schenk, M. Janner, E. Bosies, K. Strein, and H. Fleisch 1991 BM 21.0955, a potent new bisphosphonate to inhibit bone resorption. J. Bone Miner. Res., 6:1003-1011.
18. Neter, J., W. Wasserman, and G.A. Witamore 1982 Applied Statistics, Allyn and Bacon, Boston, pp. 544-572.
19. Parfitt, A.M., C.H.E. Mathews, A.R. Villanueva, M. Kleerekoper, B. Frame, and D.S. Rao 1983 Relationship between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis: Implications for the microanatomic and cellular mechanism of bone loss. J. Clin. Invest., 72:1396-1409.
20. Parfitt, M.A., M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, P.J. Meunieur, S.M. Ott, and R.R. Recker 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. J. Bone Miner. Res., 2:595-610.
21. Pataki, A., J.R. Green, H. Heizmann, K. Müller, M. Glatt, R. Schneider, and K.A. Jaeggi 1990 A histomorphometric study on the effects of the bisphosphonate CGP 42446 on rat bone. In: Osteoporosis 2:1038-1041. C. Christiansen and K. Overgaard, eds. Osteopress, Copenhagen.
22. Schenk, R., P. Eggli, H. Fleisch, and S. Rosini 1986 Quantitative morphometric evaluation of the inhibitory activity of new amino-bisphosphonates on bone resorption in the rat. Calcif. Tissue Int., 38:342-349.
23. Seedor, J.G., H.A. Quartuccio, and D.D. Thompson 1991 The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats. J. Bone Miner. Res., 6:339-346.
24. Stutzer, A., H. Fleisch, and U. Trechsel 1988 Short-and long-term effects of a single dose of bisphosphonates on retinoid-induced bone resorption in thyroparathyroidectomized rats. Calcif. Tissue Int., 43:294-299.
25. 2MDP on bone in the rat: in vivo and in vitro studies. Bone Histomorphometry. Proceedings of the Third International Workshop, Sun Valley, May 28-June 2.
26. Wronski, T.J., L.M. Dann, K.S. Scott, and L.R. Crooke 1989 Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats. Endocrinology, 125:8 10-816.